São Paulo, Brazil

José Eduardo Krieger

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.3

ph-index = 1


Company Filing History:


Years Active: 2010-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: José Eduardo Krieger: Innovator in Cardiac Biomarkers

Introduction

José Eduardo Krieger is a prominent inventor based in São Paulo, Brazil. He has made significant contributions to the field of cardiac biomarkers, particularly in the diagnosis and management of cardiac ischemia. With a total of 2 patents, his work has the potential to impact clinical practices significantly.

Latest Patents

Krieger's latest patents include groundbreaking inventions that focus on the identification and quantification of cardiac biomarkers. One of his notable patents is for "Nitrated cardiac troponin I as a biomarker of cardiac ischemia." This invention identifies a novel biomarker for cardiac ischemia, providing methods for its use in diagnosis, prognosis, and treatment management. The detection of nitrated cardiac troponin I can be achieved through immunoassay techniques and tandem mass spectrometry.

Another significant patent is the "Method of identification and quantification of proteins, isoforms of the angiotensin I converting enzyme." This invention relates to the identification of specific isoforms of angiotensin I converting enzymes, particularly the 90 kDa isoform, which serves as a genetic marker and prognostic agent for hypertension. This method aims to enhance diagnosis and therapeutic decision-making in arterial hypertension.

Career Highlights

Throughout his career, Krieger has worked with esteemed institutions, including the Universidade Federal De São Paulo (Unifesp). His research has focused on advancing the understanding of cardiac health and hypertension, contributing valuable insights to the medical community.

Collaborations

Krieger has collaborated with notable colleagues, including Gabriela Venturini Da Silva and Alexandre Da Costa Pereira. These partnerships have fostered innovation and enhanced the impact of his research in the field of cardiac biomarkers.

Conclusion

José Eduardo Krieger's contributions to the field of cardiac biomarkers exemplify the importance of innovation in medical science. His patents not only advance diagnostic techniques but also hold promise for improving patient outcomes in cardiac care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…